

Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid® OAD)
Abstract
Keywords
References
World Health Organization: Cancer Pain Relief. Geneva: WHO, 1986.
American Heart Association: AHA statement recommends doctors change approach to prescribing pain relievers for patients with or at risk for heart disease. AHA Statement, 02/26/2007. Available at http://www.heart.org/presenter.jhtml?identifier= 3045689. Accessed July 2007.
Ricci JA, Stewart WF, Chee E, et al.: Pain exacerbation as a major source of lost productive time in US workers with arthritis. Arthritis Rheum. 2005; 53: 673-681.
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000; 43: 1905-1915.
Bradley JD, Brandt KD, Katz BP, et al.: Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. New Engl J Med. 1991; 325: 87-91.
Brandt KD: Osteoarthritis. In Isselbacher KJ, Martin JB, Braunwald E, et al. (eds.): Harrison’s Principles of Internal Medicine. 13th ed. New York: McGraw-Hill, 1994: 1692-1698.
Brandt KD: Management of osteoarthritis. In Kelley WN, Harris ED, Ruddy S, et al. (eds.): Textbook of Rheumatology. 4th ed. Philadelphia: WB Saunders, 1993: 1385-1399.
Griffin MR, Piper JM, Daugherty JR, et al.: Nonsteroidal anti-inflammatory drug use and increased risk of peptic ulcer disease in elderly persons. Ann Intern Med. 1991; 114: 257-263.
Roth SH: Nonsteroidal anti-inflammatory drugs: Gastropathy, deaths, and medical practice. Ann Intern Med. 1991; 114: 257-263.
Roth SH, Bennett RE: Nonsteroidal anti-inflammatory drug gastropathy: Recognition and response. Arch Intern Med. 1988; 109: 353-354.
Schafer AI: Effects of nonsteroidal anti-inflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995; 35: 209-219.
Raffa RB, Freidrichs E: The basic science aspect of Tramadol hydrochloride. Pain Rev. 1996; 3: 249-271.
Reimann W, Schneider F: Induction of 5-hydroxytriptamine release by Tramadol, fenfluramine and reserpine. Eur J Pharmacol. 1998; 349(2/3): 199-203.
Grond S, Sablotzki A: Clinical pharmacology of Tramadol. Clin Pharmacokinet. 2004; 43: 879-923.
Grond S, Zech D, Lynch J, et al.: Tramadol: A weak opioid for relief of cancer pain. Pain Clinic. 1992; 5: 241-247.
Harati Y, Gooch C, Swensen M, et al.: Double-blind randomized trial of tramadol in the treatment of the pain of diabetic neuropathy. Neurology. 1998; 50: 1842-1846.
Sindrup SH, Andersen G, Madsen C, et al.: Tramadol relieves pain and allodynia in polyneuropathy: A randomized doubleblind controlled trial. Pain. 1999; 83: 85-90.
Jensen EM, Ginsberg F: Tramadol versus dextropropoxyphene in the treatment of osteoarthritis: A short term double-blind study. Drug Invest. 1994; 8: 211-218.
Fleischmann RM, Caldwell JR, Roth SH, et al.: Tramadol for the treatment of joint pain associated with osteoarthritis: A randomized, double-blind, placebo-controlled trial. Curr Ther Res. 2001; 62: 113-128.
Roth SH: Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol. 1998; 25: 1358-1363.
Cossman M, Kohnene C, Langford R, et al.: Tolerance and safety of tramadol use: Results of international studies and data from drug surveillance. Drugs. 1997; 53(suppl 2): 50-62.
Rahmouni M, Gervais S, Karhu D, et al.: Development and clinical evaluation of a novel once-a-day tramadol formulation. In the 32nd Annual Meeting and Exposition of the Controlled Release Society, Miami Beach, Florida, June 18-22, 2005.
Topalgic® LP: Vidal 2006: Le Dictionnaire. 82e ed. Paris: Editions du Vidal, 2006: 2102-2103.
Karhu D, Bouchard S: Comparative bioavailability of Tramadol Contramid® once-a-day and tramadol immediaterelease tablets. In The American Academy of Pain Medicine (AAPM), 23rd Annual Meeting, New Orleans, USA. Poster 145, 2007.
Karhu D, Bouchard S: Pharmacokinetic evaluation of a novel once-a-day tramadol hydrochloride formulation. In American College of Clinical Pharmacology 34th Annual Meeting, Rockville, MD, Sep 11, 2005.
Manek NJ, Lane NE: Osteoarthritis: Current concepts in diagnosis and management. Am Fam Physician. 2000; 61: 1795-1804.
Mongin G, Yakusevich V, Kope A, et al.: Efficacy and safety of a novel once-daily tablet formulation of Tramadol. Clin Drug Investig. 2004; 24: 545-558.
Lenaerts V, Moussa I, Dumoulin Y, et al.: Cross-linked high amylose starch for controlled release of drugs: Recent advances. J Control Release. 1998; 53(1-3): 225-234.
Hancock BC, Carlson GT, Ladipo DD, et al.: The powder flow and compact mechanical properties of two recently developed matrix-forming polymers. J Pharm Pharmacol. 2001; 53(9): 1193-1199.
Hernandez-Lopez C, Martinez-Farnos L, Karhu D, et al.: Comparative bioavailability between two Tramadol once-daily oral formulations. Methods Find Exp Clin Pharmacol. 2006; 28(6): 373-378.
DOI: https://doi.org/10.5055/jom.2007.0015
Refbacks
- There are currently no refbacks.